Dr. Robert Jude Joba, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 6929 Erie Rd, Derby, NY 14047 Phone: 716-947-2462 Fax: 716-947-2464 |
News Archive
Impax Laboratories, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted final approval of the Company's Abbreviated New Drug Application (ANDA) for the generic version of OPANA® ER (oxymorphone hydrochloride) Extended Release 30mg tablet. In June 2010, the Company was granted final approval for the 5mg, 10mg, 20mg, and 40mg tablets.
Genetic mutations in a form of non-small cell lung cancer (NSCLC) may drive tumor formation by blurring cells' perception of key growth signals, according to a new laboratory study published August 31, 2018 in Science.
ABC News profiles teens living with chronic diseases, and examines their insurance coverage and the cost of such care. The article notes: "Chronic diseases affect 1 in 10 Americans and are the leading cause of disability, accounting for 70 percent of all deaths, according to the Centers for Disease Control and Prevention. They are also expensive."
In a press release the U.S. Food and Drug Administration (FDA) released a plan for eliminating the backlog regarding orphan drug application status and also released plans for deadlines to clear the queues.
› Verified 2 days ago